Corvus Pharmaceuticals Ratios (2022-2025) | CRVS

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Efficiency
Assets Average 96.92M86.44M74.29M63.22M58.12M54.99M48.75M42.82M52.32M61.69M63.86M64.17M74.45M84.97M
Equity Average 85.05M72.53M60.40M52.49M49.17M46.89M41.49M36.02M42.30M31.82M22.49M40.95M64.78M76.00M
Invested Capital 89.72M80.39M64.68M56.12M48.87M49.48M44.29M38.68M33.36M51.23M12.41M32.57M49.33M80.23M71.77M
Leverage & Solvency
Equity Ratio 0.890.870.810.820.840.850.850.850.830.790.210.470.830.900.89
Valuation
Enterprise Value 44.89M17.62M13.52M26.41M32.72M98.98M51.39M73.69M79.83M99.00M325.59M335.04M211.67M293.77M546.30M
Market Capitalization 76.35M46.09M38.10M39.57M42.38M106.64M71.49M86.31M87.29M113.84M330.27M343.78M216.67M308.46M549.17M
Return Ratios
Return on Capital Employed -0.67%-0.60%-1.64%-0.53%-0.51%-0.49%
Return on Assets -0.52%-0.38%-0.88%-0.52%-0.47%-0.49%
Return on Equity -0.62%-0.47%-1.71%-0.82%-0.54%-0.54%